Breaking News: ASTRO's Groundbreaking Guideline for Gastric Cancer Treatment
In a significant development, the American Society for Radiation Oncology (ASTRO) has released its first-ever clinical guideline focused on radiation therapy for gastric (stomach) cancer patients. This guideline, published in Practical Radiation Oncology, is a comprehensive roadmap for healthcare professionals, offering evidence-based recommendations to enhance patient care.
The Global Impact of Gastric Cancer
Gastric cancer, a leading cause of cancer-related deaths worldwide, poses a significant health challenge. With over 30,000 new cases estimated in the U.S. alone in 2025, the need for effective treatment strategies is crucial. While overall stomach cancer rates have declined over the years, recent studies indicate a potential rise among middle-aged adults, underscoring the importance of timely and effective interventions.
Advancements in Treatment: A Multidisciplinary Approach
The past decade has witnessed remarkable progress in gastric cancer treatments, driven by advancements in surgery, chemotherapy, immunotherapy, and radiation therapy. For patients with resectable disease, perioperative chemotherapy regimens, administered before and after surgery, have shown improved survival rates. Additionally, the integration of immunotherapy is emerging as a promising strategy. For those unable to undergo perioperative chemotherapy, a preoperative chemoradiation approach offers an alternative, providing good local control.
Radiation Therapy's Evolving Role
Radiation therapy plays a pivotal role in gastric cancer management, especially in palliative care, helping alleviate symptoms such as bleeding and pain. The guideline emphasizes the dynamic integration of radiation therapy with other modalities, including surgery, chemotherapy, immunotherapy, and palliative care, reflecting the complex and multidisciplinary nature of gastric cancer treatment.
Key Recommendations: A Comprehensive Overview
Resectable Disease:
- Surgery and perioperative chemotherapy (FLOT regimen) are recommended for resectable gastric cancer patients.
- Pre-surgical radiation therapy with concurrent chemotherapy is advised for those ineligible for perioperative chemotherapy, aiming to achieve negative surgical margins and reduce early recurrence.
- The guideline also explores the evolving role of immunotherapy and chemoradiation therapy post-surgery for select patients.
Unresectable (Locally Advanced or Metastatic) Disease:
- Definitive radiation therapy with concurrent chemotherapy is recommended for nonmetastatic gastric cancer patients who decline or are not candidates for surgery.
- Palliative radiation therapy is suggested for locally advanced or metastatic cancer, providing symptom relief from bleeding, pain, and obstruction.
- Reirradiation may be considered in the palliative setting for some patients.
- For limited metastases outside the stomach, radiation therapy or surgery combined with systemic therapy is conditionally recommended.
Treatment Planning and Delivery:
- The guideline provides recommendations for optimal dosing and fractionation approaches, ensuring precision and minimizing side effects.
- It discusses best practices for treatment planning and delivery, including newer techniques like intensity-modulated radiation therapy and image guidance, enhancing treatment fidelity and tolerance.
Collaborative Care Decisions:
- Care decisions should involve a multidisciplinary team, including providers from all treating disciplines and the patient, ensuring a comprehensive discussion of risks and benefits to determine the best treatment approach.
About the Guideline:
- "Radiation Therapy for Gastric Cancer: An ASTRO Clinical Practice Guideline" was developed by a multidisciplinary panel, including radiation, medical, and surgical oncologists, a resident, a medical physicist, and a patient representative.
- Recommendations are based on a systematic review of research published from 2001 to mid-2025.
- The guideline is endorsed by several prestigious organizations, including ESTRO, SSO, and the American Radium Society.
ASTRO's Commitment to Patient-Centric Care:
- ASTRO's clinical guidelines serve as tools to promote individualized, shared decision-making between physicians and patients, emphasizing the importance of informed judgments.
Patient Resources:
- For patients seeking information on treatment options, RTAnswers.org provides valuable resources, including videos, PDFs, and general information on radiation therapy for esophageal and stomach cancers.
About ASTRO:
- ASTRO is the world's largest professional society dedicated to radiation oncology, with a diverse membership of over 10,000 professionals, including physicians, nurses, physicists, and more.
- Radiation therapy is a cornerstone in cancer treatment, contributing to 40% of cancer cures worldwide, with over one million Americans receiving radiation therapy annually.
- To learn more about ASTRO's initiatives and resources, visit their website and media center, and connect with them on social media.
